| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
adenylate cyclase 7 | 0.656 | 0.462 | 9.5E-07 |
|
group | 0.110 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
ETS proto-oncogene 1, transcription factor | 0.444 | 0.731 | 0.78 |
|
group | 0.110 | None | 1.000 | 1 | 1 | 2017 | 2019 | ||||||||
|
SP140 nuclear body protein | 0.691 | 0.577 | 5.0E-08 |
|
group | 0.110 | None | 0.500 | 1 | 1 | 2015 | 2018 | ||||||||
|
FTO alpha-ketoglutarate dependent dioxygenase | 0.486 | 0.885 | 8.4E-08 |
|
group | 0.110 | None | 1.000 | 1 | 1 | 2017 | 2019 | ||||||||
|
cadherin EGF LAG seven-pass G-type receptor 3 | 0.716 | 0.423 | 1.00 |
|
group | 0.110 | None | 1.000 | 1 | 1 | 2015 | 2019 | ||||||||
|
tet methylcytosine dioxygenase 2 | 0.458 | 0.808 | 4.3E-54 |
|
group | 0.110 | None | 1.000 | 1 | 1 | 2015 | 2019 | ||||||||
|
phospholipase A2 group IVA | 0.496 | 0.846 | 6.0E-05 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
histone deacetylase 7 | 0.597 | 0.654 | 1.00 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
SUFU negative regulator of hedgehog signaling | 0.493 | 0.769 | 1.00 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
plasminogen activator, urokinase | 0.425 | 0.923 | 2.3E-06 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
notch receptor 1 | 0.369 | 0.885 | 1.00 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 2 | 0.617 | 0.769 | 1.0E-05 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
LIM domain containing preferred translocation partner in lipoma | 0.543 | 0.769 | 7.2E-03 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
Grid2 interacting protein | 0.12 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||||
|
cullin 1 | 0.617 | 0.615 | 1.00 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
proteasome assembly chaperone 4 | 0.931 | 0.154 | 1.9E-03 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
interferon regulatory factor 6 | 0.486 | 0.769 | 1.00 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
chromosome 10 open reading frame 55 (putative) | 0.931 | 0.115 | 1.4E-02 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
chromosome 17 open reading frame 67 | 0.792 | 0.308 | 6.5E-06 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
EEF1A lysine methyltransferase 2 | 1.000 | 0.038 | 2.3E-07 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
dual specificity phosphatase and pro isomerase domain containing 1 | 1.000 | 0.038 | 2.5E-07 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
interphotoreceptor matrix proteoglycan 2 | 0.659 | 0.308 | 2.8E-13 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
bromodomain containing 2 | 0.450 | 0.808 | 1.00 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
transmembrane 9 superfamily member 4 | 0.821 | 0.154 | 1.00 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
dual specificity phosphatase 16 | 0.743 | 0.385 | 8.9E-02 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 |